BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Díez JJ, Sangiao-Alvarellos S, Cordido F. Treatment with Growth Hormone for Adults with Growth Hormone Deficiency Syndrome: Benefits and Risks. Int J Mol Sci 2018;19:E893. [PMID: 29562611 DOI: 10.3390/ijms19030893] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Sjöström A, Chisalita SI, Höybye C. Copeptin in Growth Hormone-Treated Patients. JCM 2022;11:5510. [DOI: 10.3390/jcm11195510] [Reference Citation Analysis]
2 Rossi F, Tortora C, Paoletta M, Marrapodi MM, Argenziano M, Di Paola A, Pota E, Di Pinto D, Di Martino M, Iolascon G. Osteoporosis in Childhood Cancer Survivors: Physiopathology, Prevention, Therapy and Future Perspectives. Cancers 2022;14:4349. [DOI: 10.3390/cancers14184349] [Reference Citation Analysis]
3 Esefeld M, Pastor A, de la Torre R, Barroso O, Aikin R, Sarwath H, Engelke R, Schmidt F, Suhre K. The Proteomic Signature of Recombinant Growth Hormone in Recreational Athletes. J Endocr Soc 2021;5:bvab156. [PMID: 34765854 DOI: 10.1210/jendso/bvab156] [Reference Citation Analysis]
4 Iwata S, Tsumura K, Ashida K, Tokubuchi I, Demiya M, Kitamura M, Ohshima H, Yano M, Nagayama A, Yasuda J, Tsuruta M, Motomura S, Yoshida S, Nomura M. Thyroid-related ophthalmopathy development in concurrence with growth hormone administration. BMC Endocr Disord 2021;21:168. [PMID: 34412613 DOI: 10.1186/s12902-021-00834-2] [Reference Citation Analysis]
5 Castoldi RC, Giometti IC, Ozaki GAT, Garcia TA, Ueno MJP, Fernandes F, Dornelles RCM, Louzada MJQ, Filho JCSC, Belangero WD. Strength training and growth hormone: effects on bone of Wistar rats. Sport Sci Health 2022;18:137-45. [DOI: 10.1007/s11332-021-00784-1] [Reference Citation Analysis]
6 Jimenez-Munoz CM, López M, Albericio F, Makowski K. Targeting Energy Expenditure-Drugs for Obesity Treatment. Pharmaceuticals (Basel) 2021;14:435. [PMID: 34066399 DOI: 10.3390/ph14050435] [Reference Citation Analysis]
7 Johansson M, Ricci F, Schulte J, Persson M, Melander O, Sutton R, Hamrefors V, Fedorowski A. Circulating levels of growth hormone in postural orthostatic tachycardia syndrome. Sci Rep 2021;11:8575. [PMID: 33883597 DOI: 10.1038/s41598-021-87983-5] [Reference Citation Analysis]
8 Biagetti B, Simó R. GH/IGF-1 Abnormalities and Muscle Impairment: From Basic Research to Clinical Practice. Int J Mol Sci 2021;22:E415. [PMID: 33401779 DOI: 10.3390/ijms22010415] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang Z, Wang Y, Gao Y, Li Z, Zhang S, Lin X, Hou Z, Yu Q, Wang X, Liu S. Morphological changes of the cerebral cortex between children with isolated growth hormone deficiency and idiopathic short stature. Brain Res 2020;1748:147081. [PMID: 32882231 DOI: 10.1016/j.brainres.2020.147081] [Reference Citation Analysis]
10 Yuen KCJ. Growth hormone deficiency, acromegaly and COVID-19: Transitioning from media reports to knowledge and a growth hormone hypothesis. Growth Horm IGF Res 2021;56:101363. [PMID: 33221709 DOI: 10.1016/j.ghir.2020.101363] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Moreira A, Lawson D, Onyekuru L, Dziemidowicz K, Angkawinitwong U, Costa PF, Radacsi N, Williams GR. Protein encapsulation by electrospinning and electrospraying. J Control Release 2021;329:1172-97. [PMID: 33127450 DOI: 10.1016/j.jconrel.2020.10.046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
12 Beck-Peccoz P, Höybye C, Murray RD, Simsek S, Zabransky M, Zouater H, Stalla G. Malignancy risk in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from the PATRO Adults study. Ther Adv Endocrinol Metab 2020;11:2042018820943377. [PMID: 32973992 DOI: 10.1177/2042018820943377] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hacioglu A, Kelestimur F, Tanriverdi F. Long-term neuroendocrine consequences of traumatic brain injury and strategies for management. Expert Rev Endocrinol Metab 2020;15:123-39. [PMID: 32133881 DOI: 10.1080/17446651.2020.1733411] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Häfner SJ. The body's integrated repair kit: Studying mesenchymal stem cells for better ligament repair. Biomed J 2019;42:365-70. [PMID: 31948600 DOI: 10.1016/j.bj.2019.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Wang X, Wang S, Wu H, Jiang M, Xue H, Zhu Y, Wang C, Zha X, Wen Y. Human growth hormone level decreased in women aged <60 years but increased in men aged >50 years. Medicine (Baltimore) 2020;99:e18440. [PMID: 31914017 DOI: 10.1097/MD.0000000000018440] [Reference Citation Analysis]
16 Beck-Peccoz P, Höybye C, Murray RD, Simsek S, Zabransky M, Zouater H, Stalla G. No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study. BMC Endocr Disord 2019;19:138. [PMID: 31829160 DOI: 10.1186/s12902-019-0464-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
17 Kobylińska M, Malak R, Majewska K, Kędzia A, Samborski W. Assessment of anterior-posterior spinal curvatures in children suffering from hypopituitarism. BMC Endocr Disord 2019;19:137. [PMID: 31829163 DOI: 10.1186/s12902-019-0462-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Lutsenko AS, Nagaeva EV, Belaya ZE, Chukhacheva OS, Zenkova TS, Melnichenko GA. [Current aspects of diagnosis and treatment of adult GH-deficiency]. Probl Endokrinol (Mosk) 2019;65:373-88. [PMID: 32202742 DOI: 10.14341/probl10322] [Reference Citation Analysis]
19 Yuen KCJ, Llahana S, Miller BS. Adult growth hormone deficiency: clinical advances and approaches to improve adherence. Expert Rev Endocrinol Metab 2019;14:419-36. [PMID: 31721610 DOI: 10.1080/17446651.2019.1689119] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
20 Weber MM, Gordon MB, Höybye C, Jørgensen JOL, Puras G, Popovic-Brkic V, Molitch ME, Ostrow V, Holot N, Pietropoli A, Biller BMK. Growth hormone replacement in adults: Real-world data from two large studies in US and Europe. Growth Horm IGF Res 2020;50:71-82. [PMID: 31972476 DOI: 10.1016/j.ghir.2019.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Leone S, Chiavaroli A, Recinella L, Orlando G, Ferrante C, Marconi GD, Gasparo I, Bitto A, Salvatori R, Brunetti L. Increased pain and inflammatory sensitivity in growth hormone-releasing hormone (GHRH) knockout mice. Prostaglandins Other Lipid Mediat 2019;144:106362. [PMID: 31301405 DOI: 10.1016/j.prostaglandins.2019.106362] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
22 Castoldi RC, Ozaki GAT, Garcia TA, Giometti IC, Koike TE, Camargo RCT, Dos Santos Pereira JDA, Constantino CJL, Louzada MJQ, Camargo Filho JCS, Belangero WD. Effects of muscular strength training and growth hormone (GH) supplementation on femoral bone tissue: analysis by Raman spectroscopy, dual-energy X-ray absorptiometry, and mechanical resistance. Lasers Med Sci 2020;35:345-54. [PMID: 31201667 DOI: 10.1007/s10103-019-02821-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Zheng X, Cheng Q, Long J, Wang Y, Gong L, Wei Q, Luo R, Liao K, Ren W. Prevalence of low lean mass in patients with adult growth hormone deficiency with or without low-dose growth hormone therapy. Clin Endocrinol (Oxf) 2019;90:834-41. [PMID: 30817014 DOI: 10.1111/cen.13958] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
24 Fares F, Azzam N. Development of long-acting recombinant glycoprotein hormones by increasing the carbohydrate content. Drug Discov Today 2019;24:1017-22. [PMID: 30711574 DOI: 10.1016/j.drudis.2019.01.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]